Outcome of urinary bladder cancer after combined therapies
about
Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway.LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma.Urine cytology screening of French workers exposed to occupational urinary tract carcinogens: a prospective cohort study over a 20-year period.Long non-coding RNA CDKN2B antisense RNA 1 gene inhibits Gemcitabine sensitivity in bladder urothelial carcinoma.
P2860
Outcome of urinary bladder cancer after combined therapies
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Outcome of urinary bladder cancer after combined therapies
@ast
Outcome of urinary bladder cancer after combined therapies
@en
Outcome of urinary bladder cancer after combined therapies
@nl
type
label
Outcome of urinary bladder cancer after combined therapies
@ast
Outcome of urinary bladder cancer after combined therapies
@en
Outcome of urinary bladder cancer after combined therapies
@nl
prefLabel
Outcome of urinary bladder cancer after combined therapies
@ast
Outcome of urinary bladder cancer after combined therapies
@en
Outcome of urinary bladder cancer after combined therapies
@nl
P2093
P2860
P1476
Outcome of urinary bladder cancer after combined therapies
@en
P2093
Trifanescu OG
P2860
P304
P407
P577
2016-01-01T00:00:00Z